Hypothesis: Restrictions on Hydroxychloroquine Contribute to the COVID-19 Cases Surge

Although Hydroxychloroquine remains an approved drug and doctors can still prescribe it off-label, the FDA’s and NIH’s opinions have significant influence. State governments and medical boards adhere to the FDA opinion, in their subsequent recommendations. Even when HCQ is not banned outright, such opinion creates a chilling effect on pharmacies, doctors, hospitals, and, especially insurance companies.

Lancet, New England Journal retract Covid-19 studies, including one that raised safety concerns about malaria drugs

From Stat By Andrew Joseph @DrewQJoseph June 4, 2020Reprints The Lancet, one of the world’s top medical journals, on Thursday retracted an influential study that raised alarms about the safety of the experimental Covid-19 treatments chloroquine and hydroxychloroquine amid scrutiny of the data underlying the paper. Just over an hour later, the New England Journal…

Nevermind…Maybe HCQ not so bad.

As noted previously by Leo Goldstein, there has been a coordinated attempt by institutional press and academia to discredit the use of Hydroxychloroquine. https://wattsupwiththat.com/2020/05/11/distributed-denial-of-hcq-to-covid-19-victims/ As noted in yesterday’s edition of Science: A mysterious company’s coronavirus papers in top medical journals may be unraveling By Kelly Servick, Martin EnserinkJun. 2, 2020 , 7:55 PM On its…